Pieper Steven
SEC CIK 1875714 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| XERS | Xeris Biopharma Holdings, Inc. | See Remarks | 1.36M | $104.6K | $468.2K | 17 | 2021-10-05 | 2026-09-01 |
Most active insiders at XERS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Hecht Beth | See Remarks | — | $1.31M |
| 2 | McCulloch Kevin | See Remarks | — | $1.09M |
| 3 | JOHNSON JOHN | Dir | — | $1.07M |
| 4 | Pieper Steven | See Remarks | — | $468.2K |
| 5 | Shannon John Patrick Jr | See Remarks, Dir | — | $349.7K |
| 6 | BORMANN-KENNEDY BARBARA-JEAN ANNE | Dir | — | $203.9K |
| 7 | HALKUFF DAWN | Dir | — | $121.9K |
| 8 | PERSKY MARLA | Dir | — | $91.4K |
| 9 | Brady James Aloysius | Dir | — | $60.0K |
| 10 | Nguyen Anh Tu | See Remarks | — | — |
Transactions 17
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-09-01 18:20 | 2026-09-01 | XERS | Xeris Biopharma Holdings, Inc. | Pieper Steven | See Remarks | S - Sale | $8.50 | -5,000 | 1.36M | -0.4% | -$42.5K |
| T | 2026-08-12 16:44 | 2026-08-12 | XERS | Xeris Biopharma Holdings, Inc. | Pieper Steven | See Remarks | S - Sale | $8.50 | -5,000 | 1.36M | -0.4% | -$42.5K |
| MT | 2026-07-07 17:11 | 2026-07-06+ | XERS | Xeris Biopharma Holdings, Inc. | Pieper Steven | See Remarks | S - Sale | $8.52 | -45.0K | 1.37M | -3% | -$383.2K |
| DM | 2026-03-05 | 2026-03-05 | XERS | Xeris Biopharma Holdings, Inc. | Pieper Steven | See Remarks | M - OptEx | $4.71 | +41.9K | 1.39M | +3% | +$197.3K |
| DM | 2026-02-02 | 2026-01-31 | XERS | Xeris Biopharma Holdings, Inc. | Pieper Steven | See Remarks | F - Tax | $7.36 | -205.5K | 1.46M | -12% | -$1.51M |
| D | 2026-02-02 | 2026-01-30 | XERS | Xeris Biopharma Holdings, Inc. | Pieper Steven | See Remarks | A - Grant | $0.00 | +155.0K | 1.57M | +11% | $0 |
| DM | 2025-02-03 | 2025-01-31 | XERS | Xeris Biopharma Holdings, Inc. | Pieper Steven | See Remarks | F - Tax | $3.56 | -177.2K | 1.30M | -12% | -$630.8K |
| D | 2025-02-03 | 2025-01-31 | XERS | Xeris Biopharma Holdings, Inc. | Pieper Steven | See Remarks | A - Grant | $0.00 | +185.0K | 1.42M | +15% | $0 |
| 2025-01-07 | 2025-01-03 | XERS | Xeris Biopharma Holdings, Inc. | Pieper Steven | See Remarks | F - Tax | $3.61 | -32.1K | 1.41M | -2% | -$115.7K | |
| D | 2024-11-26 | 2024-11-22 | XERS | Xeris Biopharma Holdings, Inc. | Pieper Steven | See Remarks | M - OptEx | $1.55 | +19.5K | 1.44M | +1% | +$30.2K |
| M | 2024-08-09 | 2022-01-29+ | XERS | Xeris Biopharma Holdings, Inc. | Pieper Steven | See Remarks | F - Tax | $2.22 | -204.6K | 1.42M | -13% | -$454.3K |
| 2024-01-31 | 2024-01-31 | XERS | Xeris Biopharma Holdings, Inc. | Pieper Steven | See Remarks | A - Grant | $0.00 | +450.0K | 1.63M | +38% | $0 | |
| 2023-11-21 | 2023-11-20 | XERS | Xeris Biopharma Holdings, Inc. | Pieper Steven | See Remarks | P - Purchase | $1.95 | +28.0K | 1.18M | +2% | +$54.6K | |
| 2023-02-01 | 2023-01-31 | XERS | Xeris Biopharma Holdings, Inc. | Pieper Steven | See Remarks | A - Grant | $0.00 | +750.0K | 1.15M | +188% | $0 | |
| 2022-01-05 | 2022-01-03 | XERS | Xeris Biopharma Holdings, Inc. | Pieper Steven | See Remarks | A - Grant | $0.00 | +200.0K | 388.8K | +106% | $0 | |
| 2021-11-12 | 2021-11-10 | XERS | Xeris Biopharma Holdings, Inc. | Pieper Steven | See Remarks | P - Purchase | $2.00 | +25.0K | 183.1K | +16% | +$50.0K | |
| DM | 2021-10-05 | 2021-10-05 | XERS | Xeris Biopharma Holdings, Inc. | Pieper Steven | CFO | A - Grant | — | +158.1K | 158.1K | New | — |
Purchase Sale Sale after option exercise All abbreviations